SimonMed Imaging, one of the nation’s largest outpatient medical imaging providers, has launched an AI-powered digital health platform designed to address a persistent gap in women’s health: completion of recommended follow-up imaging after mammography. Studies indicate that up to 30% of women do not complete recommended follow-up imaging after a screening mammogram, particularly those with dense breast tissue or high-risk profiles where additional ultrasound or breast MRI represents a critical next step for early breast cancer detection.
The platform, powered by technology from Cascaid Health, transforms SimonMed’s AI-enhanced Mammogram+ breast screening results into personalized, interactive mobile experiences. Rather than static PDF reports or federally mandated lay letters, women receive mobile-accessible reports with educational videos, AI health guidance, and direct connection to human navigators for scheduling and questions within a HIPAA-compliant portal.
Closing the Follow-Up Gap
The follow-up completion problem SimonMed targets represents a well-documented challenge in breast cancer screening. Research on mammography follow-up indicates that failure to complete recommended imaging contributes to delayed diagnosis, later-stage detection, and worse outcomes, particularly among women with dense breast tissue where supplemental screening provides the greatest clinical value.
Many women fall through the cracks due to lack of information, unclear next steps, or logistical barriers such as obtaining physician orders, according to the company. The digital platform aims to remove these friction points by delivering personalized guidance and streamlining the path to follow-up care.
“Studies show up to 30% of women don’t receive recommended follow-up imaging after a high-risk or inconclusive mammogram—a gap that can mean the difference between catching a cancer early or too late. We built this platform to close that gap.” — Dr. John Simon, Founder and CEO, SimonMed Imaging
“Early detection only saves lives if it’s followed by timely action,” said Dr. John Simon, Founder and CEO of SimonMed Imaging. “Studies show up to 30% of women don’t receive recommended follow-up imaging after a high-risk or inconclusive mammogram, a gap that can mean the difference between catching a cancer early or too late. We built this platform to close that gap and make it easier for every woman to understand her results and take the next step in her care.”
Beyond Static Reports
The platform builds on SimonMed’s existing Mammogram+ program, which uses AI to analyze breast density and calculate lifetime risk scores to identify each patient’s unique screening needs. The digital health experience takes this data and creates what SimonMed describes as Netflix-style personalization for healthcare, delivering intuitive, data-driven content tailored to each woman’s imaging and health history.
“Women deserve the same level of personalization from healthcare that they get from platforms like Spotify or Netflix. Our digital health platform takes the data we already have and turns it into something patients can easily understand and act on.” — Jenna Lloyd, Chief Marketing Officer, SimonMed Imaging
According to Jenna Lloyd, Chief Marketing Officer at SimonMed Imaging, “Women deserve the same level of personalization from healthcare that they get from platforms like Spotify or Netflix. Our digital health platform takes the data we already have—breast density, lifetime risk scores, and AI insights—and turns it into something patients can easily understand and act on. It delivers an intuitive, data-driven experience that brings together each woman’s imaging and health history into personalized insights, education, and next steps, all conveniently accessible on her phone.”
The mobile portal allows patients to view their results, watch educational videos explaining their findings, interact with an AI health guide for common questions, and connect with human navigators for scheduling or clinical questions. The system maintains provider coordination by sending integrated updates to referring physicians, primary care providers, and radiologists.
Technology Integration and Clinical Intelligence
Cascaid Health’s CORTEX AI platform provides the clinical-grade intelligence behind SimonMed’s patient-facing experience, transforming advanced imaging data into actionable guidance. The technology represents a shift from passive result delivery to active patient engagement, according to the companies.
“By pairing SimonMed’s diagnostic expertise with Cascaid’s integrated technology, we’re transforming imaging results into actionable insights that empower women to act early, stay engaged, and take control of their long-term health.” — Dr. Rakesh Patel, Founder and CEO, Cascaid Health
“Early detection is just the starting point,” said Dr. Rakesh Patel, Founder and CEO of Cascaid Health. “By pairing SimonMed’s diagnostic expertise with Cascaid’s integrated technology, we’re transforming imaging results into actionable insights that empower women to act early, stay engaged, and take control of their long-term health.”
The platform addresses what both companies identify as a fundamental problem in breast imaging: women receive complex medical information but often lack the context, education, and navigation support needed to act on it effectively. Dense breast tissue notifications, lifetime risk scores, and recommendations for supplemental screening carry significant implications, yet many patients struggle to understand what these findings mean or how to proceed.
Market Context and Patient Navigation
SimonMed’s platform launch reflects broader recognition within medical imaging that technology-enhanced patient engagement represents both a clinical imperative and a competitive differentiator. With approximately 170 sites across 11 states, SimonMed has positioned itself as an early adopter of AI in breast imaging, deploying multiple FDA-cleared AI systems (from Lunit, Therapixel, and iCAD) as part of its Mammogram+ and Mammogram+ Heart programs.
The company’s focus on follow-up completion addresses a gap that patient navigation programs have historically targeted through human-intensive outreach. By automating initial engagement and education while maintaining human navigator availability for complex questions or scheduling assistance, SimonMed aims to scale personalized support more efficiently than traditional navigation models.
Whether the platform delivers measurable improvements in follow-up completion rates, time to diagnostic resolution, and early-stage cancer detection will require longitudinal data and clinical validation. SimonMed has not disclosed specific performance metrics or completion rate targets for the platform.
The success of digital patient engagement platforms in mammography ultimately depends on several factors: user adoption rates, integration with existing clinical workflows, impact on staff workload (positive or negative), and most critically, whether automated engagement and AI guidance actually move the needle on follow-up completion among the highest-risk populations where gaps are most consequential.
For providers considering similar patient engagement investments, SimonMed’s approach offers a test case for whether mobile-first, AI-enhanced communication can address systemic follow-up gaps more effectively than conventional notification and navigation methods. Early detection saves lives only when coupled with timely follow-up, making follow-up completion rates an increasingly important quality metric for breast imaging centers.
A video demonstration of the SimonMed powered by Cascaid Health mobile reports is available here.
– This original article was created with AI support.
